Uzbek researchers have developed a groundbreaking treatment that could transform how Parkinson’s disease is managed. Specialists from the Institute of the Chemistry of Plant Substances at the Academy of Sciences of Uzbekistan have created an innovative drug designed not only to relieve symptoms but also to help prevent the progression of this debilitating neurological condition, Podrobno.uz reports.
The drug has been officially registered in the national registry under the number IAP 8162. According to its developers, it has shown a low rate of side effects, making it potentially safe for widespread use among patients.
Until now, Parkinson’s disease has been considered incurable, gradually destroying the brain’s dopamine-producing neurons and causing a buildup of the protein alpha-synuclein, which impairs cellular function.
“Intervening in this process was long thought impossible. But in Uzbekistan, even global-level innovation is within reach,” one of the researchers emphasized.
Parkinson’s disease is among the most common neurodegenerative disorders worldwide. According to the World Health Organization, more than 8 million people currently live with the condition. Up to now, available treatments have only been able to slow the progression of symptoms rather than halt the disease itself.
The Uzbek discovery could mark a major breakthrough in the global fight against Parkinson’s.
According to the Global Burden of Disease Study 2021, the number of people living with Parkinson’s reached 11.8 million in 2021. Forecasts published by BMJ predict that the number may rise to 25.2 million by 2050. Based on current trends, the global Parkinson’s population in 2025 is estimated to be around 14 million.
CentralasianLIGHT.org
August 7, 2025